Genetically engineered bacteria to identify and produce medically important agents
US5532124A · kind A · utility
4Cited by
0References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 6, 1993 |
| Grant date | Jul 2, 1996 |
| Priority date | — |
| Expiry date | Oct 6, 2013 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S435/974
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Microorganisms modified such that their growth in selective media is dependent upon the inhibition of a medically important target function are provided and utilized in methods for the screening of potential medically important compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.